The Level of Anti-Viral Antigen-Specific Antibodies to EBNA-1 in the Serum of MS Patients Does not Depend on the Severity of the Disease

Multiple sclerosis (MS) is an autoimmune neurodegenerative disease leading to inevitable disability and primarily affecting the young and middle-aged population. Recent studies have shown a direct correlation between the risk of MS development and Epstein–Barr virus (EBV) infection. Analysis of the...

Full description

Saved in:
Bibliographic Details
Published in:Doklady. Biochemistry and biophysics Vol. 515; no. 1; pp. 48 - 51
Main Authors: Ovchinnikova, L. A., Dzhelad, S. S., Simaniv, T. O., Zakharova, M. N., Gabibov, A. G., Lomakin, Y. A.
Format: Journal Article
Language:English
Published: Moscow Pleiades Publishing 01.04.2024
Springer Nature B.V
Subjects:
ISSN:1607-6729, 1608-3091, 1608-3091
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Multiple sclerosis (MS) is an autoimmune neurodegenerative disease leading to inevitable disability and primarily affecting the young and middle-aged population. Recent studies have shown a direct correlation between the risk of MS development and Epstein–Barr virus (EBV) infection. Analysis of the titer of EBV-specific antibodies among patients with MS and healthy donors among Russian population confirmed that MS is characterized by an increased level of serum IgG binding EBNA-1 (EBV nuclear antigen 1). The number of patients with elevated levels of EBNA-1-specific antibodies does not differ statistically significantly between two groups with diametrically opposite courses of MS: benign MS or highly active MS. It can be assumed that the primary link between EBV and the development of MS is restricted to the initiation of the disease and does not impact its severity.
AbstractList Multiple sclerosis (MS) is an autoimmune neurodegenerative disease leading to inevitable disability and primarily affecting the young and middle-aged population. Recent studies have shown a direct correlation between the risk of MS development and Epstein–Barr virus (EBV) infection. Analysis of the titer of EBV-specific antibodies among patients with MS and healthy donors among Russian population confirmed that MS is characterized by an increased level of serum IgG binding EBNA-1 (EBV nuclear antigen 1). The number of patients with elevated levels of EBNA-1-specific antibodies does not differ statistically significantly between two groups with diametrically opposite courses of MS: benign MS or highly active MS. It can be assumed that the primary link between EBV and the development of MS is restricted to the initiation of the disease and does not impact its severity.
Multiple sclerosis (MS) is an autoimmune neurodegenerative disease leading to inevitable disability and primarily affecting the young and middle-aged population. Recent studies have shown a direct correlation between the risk of MS development and Epstein-Barr virus (EBV) infection. Analysis of the titer of EBV-specific antibodies among patients with MS and healthy donors among Russian population confirmed that MS is characterized by an increased level of serum IgG binding EBNA-1 (EBV nuclear antigen 1). The number of patients with elevated levels of EBNA-1-specific antibodies does not differ statistically significantly between two groups with diametrically opposite courses of MS: benign MS or highly active MS. It can be assumed that the primary link between EBV and the development of MS is restricted to the initiation of the disease and does not impact its severity.Multiple sclerosis (MS) is an autoimmune neurodegenerative disease leading to inevitable disability and primarily affecting the young and middle-aged population. Recent studies have shown a direct correlation between the risk of MS development and Epstein-Barr virus (EBV) infection. Analysis of the titer of EBV-specific antibodies among patients with MS and healthy donors among Russian population confirmed that MS is characterized by an increased level of serum IgG binding EBNA-1 (EBV nuclear antigen 1). The number of patients with elevated levels of EBNA-1-specific antibodies does not differ statistically significantly between two groups with diametrically opposite courses of MS: benign MS or highly active MS. It can be assumed that the primary link between EBV and the development of MS is restricted to the initiation of the disease and does not impact its severity.
Author Dzhelad, S. S.
Zakharova, M. N.
Ovchinnikova, L. A.
Lomakin, Y. A.
Simaniv, T. O.
Gabibov, A. G.
Author_xml – sequence: 1
  givenname: L. A.
  surname: Ovchinnikova
  fullname: Ovchinnikova, L. A.
  organization: Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
– sequence: 2
  givenname: S. S.
  surname: Dzhelad
  fullname: Dzhelad, S. S.
  organization: Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
– sequence: 3
  givenname: T. O.
  surname: Simaniv
  fullname: Simaniv, T. O.
  organization: Research Center of Neurology
– sequence: 4
  givenname: M. N.
  surname: Zakharova
  fullname: Zakharova, M. N.
  organization: Research Center of Neurology
– sequence: 5
  givenname: A. G.
  surname: Gabibov
  fullname: Gabibov, A. G.
  email: gabibov@gmail.com
  organization: Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow State University
– sequence: 6
  givenname: Y. A.
  surname: Lomakin
  fullname: Lomakin, Y. A.
  email: yasha.l@bk.ru
  organization: Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38472667$$D View this record in MEDLINE/PubMed
BookMark eNp9kstuEzEUhi1URC_wAGyQJTZsBnyZsccrFJoWkMJFSmFrTTzHqauJHWwnUt-Ax64naQsUwcrHx9__-z-yj9GBDx4Qek7Ja0p5_WZOBZFCMsVqSYhs-CN0VFptxYmiB7taVuP5ITpO6YoQRhhvnqBD3taSCSGP0M-LS8Az2MKAg8UTn1313cVu2JVL8NV8DcZZZ3aNRegdJJwDPnv3eVJR7DzOxWAOcbMaDT7N8dcuO_A54WkoqA8ZT2ENvsfhjt1CdPl6xMf91CXoEjxFj203JHh2u56gb-dnF6cfqtmX9x9PJ7PK1JLmqqOstlJ0tK6VMdTazhrFZVMzVUtOetEuBAHFe6XaVinb8542VigGlNAFNfwEvd37rjeLFfSmRC3j6nV0qy5e69A5_eeJd5d6GbaaUsIoY6Q4vLp1iOHHBlLWK5cMDEPnIWySZqoRoqWtFAV9-QC9Cpvoy3yas6aE5qQZDV_8Huk-y90rFYDuARNDShHsPUKJHn-C_usnFI18oDEul6cJ41Ru-K-S7ZWp3OKXEH-F_rfoBr7kw74
CitedBy_id crossref_primary_10_1016_j_isci_2025_113048
Cites_doi 10.1038/s41586-022-04432-7
10.1212/WNL.33.11.1444
10.3389/fimmu.2017.00777
10.1126/science.abj8222
10.1038/emm.2014.84
10.3389/fimmu.2022.803229
10.32607/actanaturae.11794
10.1016/j.meegid.2023.105443
10.1007/s11910-012-0292-5
10.1016/j.msard.2019.01.039
10.1016/j.neuron.2018.01.021
10.1136/jnnp-2023-331868
ContentType Journal Article
Copyright The Author(s) 2024. ISSN 1607-6729, Doklady Biochemistry and Biophysics, 2024, Vol. 515, pp. 48–51. © The Author(s), 2024. This article is an open access publication. ISSN 1607-6729, Doklady Biochemistry and Biophysics, 2024. © The Author(s), 2024. This article is an open access publication.
2024. The Author(s).
The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2024, ISSN 1607-6729, Doklady Biochemistry and Biophysics, 2024, Vol. 515, pp. 48–51. © The Author(s), 2024. This article is an open access publication.ISSN 1607-6729, Doklady Biochemistry and Biophysics, 2024. © The Author(s), 2024. This article is an open access publication.
Copyright_xml – notice: The Author(s) 2024. ISSN 1607-6729, Doklady Biochemistry and Biophysics, 2024, Vol. 515, pp. 48–51. © The Author(s), 2024. This article is an open access publication. ISSN 1607-6729, Doklady Biochemistry and Biophysics, 2024. © The Author(s), 2024. This article is an open access publication.
– notice: 2024. The Author(s).
– notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2024, ISSN 1607-6729, Doklady Biochemistry and Biophysics, 2024, Vol. 515, pp. 48–51. © The Author(s), 2024. This article is an open access publication.ISSN 1607-6729, Doklady Biochemistry and Biophysics, 2024. © The Author(s), 2024. This article is an open access publication.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7QR
7T5
7TK
7TM
7X7
7XB
88A
88E
88I
8AO
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOI 10.1134/S1607672924700753
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Immunology Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Journals
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Collection (ProQuest)
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Science Database (ProQuest)
Biological Science Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

MEDLINE
ProQuest Central Student
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Biology
EISSN 1608-3091
EndPage 51
ExternalDocumentID PMC11021220
38472667
10_1134_S1607672924700753
Genre Journal Article
GroupedDBID ---
-56
-5G
-BR
-EM
-Y2
-~C
-~X
.86
.VR
06C
06D
0R~
0VY
1N0
29G
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3V.
4.4
408
409
40D
40E
53G
5GY
5VS
67N
67Z
6NX
7X7
88A
88E
88I
8AO
8CJ
8FE
8FH
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDBF
ABDZT
ABECU
ABFTV
ABHQN
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACGOD
ACHSB
ACHXU
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACSNA
ACUHS
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEMSY
AENEX
AEOHA
AEPYU
AETLH
AEVLU
AEXYK
AFBBN
AFGCZ
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B-.
B0M
BA0
BBNVY
BDATZ
BENPR
BGNMA
BHPHI
BPHCQ
BSONS
BVXVI
C6C
CAG
CCPQU
COF
CS3
CSCUP
D1J
DDRTE
DL5
DNIVK
DPUIP
DU5
DWQXO
EAD
EAP
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMK
EMOBN
EN4
EPL
ESBYG
ESX
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
GQ8
GXS
H13
HCIFZ
HF~
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
IHE
IJ-
IKXTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
JBSCW
JCJTX
JZLTJ
KDC
KOV
KPH
LAK
LK8
LLZTM
M0L
M1P
M2P
M4Y
M7P
MA-
N2Q
NB0
NPVJJ
NQJWS
NU0
O9-
O93
O9I
O9J
OAM
OVD
PF0
PQQKQ
PROAC
PSQYO
PT4
Q2X
QOR
QOS
R89
R9I
RNI
RNS
ROL
RPX
RSV
RZC
RZE
S16
S1Z
S27
S3A
S3B
SAP
SBL
SDH
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
STPWE
SV3
SZN
T13
TEORI
TSG
TSK
TSV
TUC
TUS
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
XU3
YLTOR
ZMTXR
ZOVNA
~8M
~A9
~KM
AAPKM
AAYXX
ABDBE
ABFSG
ABRTQ
ACSTC
ADHKG
AEZWR
AFDZB
AFFHD
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7QR
7T5
7TK
7TM
7XB
8FD
8FK
FR3
H94
K9.
P64
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c471t-a124f76a1449cc1ffafc93754294730d68b60e93d998899fd3d15f692e101b1c3
IEDL.DBID RSV
ISICitedReferencesCount 1
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001180964600004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1607-6729
1608-3091
IngestDate Tue Nov 04 02:05:48 EST 2025
Thu Oct 02 09:57:23 EDT 2025
Tue Oct 07 05:51:29 EDT 2025
Thu Apr 03 06:53:28 EDT 2025
Sat Nov 29 06:25:12 EST 2025
Tue Nov 18 21:29:41 EST 2025
Fri Feb 21 02:42:02 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords EBNA-1
EBV
autoantibodies
MS
multiple sclerosis
Epstein–Barr virus
Language English
License 2024. The Author(s).
Open Access.This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c471t-a124f76a1449cc1ffafc93754294730d68b60e93d998899fd3d15f692e101b1c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://link.springer.com/10.1134/S1607672924700753
PMID 38472667
PQID 3255423050
PQPubID 55382
PageCount 4
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11021220
proquest_miscellaneous_2956681876
proquest_journals_3255423050
pubmed_primary_38472667
crossref_primary_10_1134_S1607672924700753
crossref_citationtrail_10_1134_S1607672924700753
springer_journals_10_1134_S1607672924700753
PublicationCentury 2000
PublicationDate 2024-04-01
PublicationDateYYYYMMDD 2024-04-01
PublicationDate_xml – month: 04
  year: 2024
  text: 2024-04-01
  day: 01
PublicationDecade 2020
PublicationPlace Moscow
PublicationPlace_xml – name: Moscow
– name: United States
PublicationTitle Doklady. Biochemistry and biophysics
PublicationTitleAbbrev Dokl Biochem Biophys
PublicationTitleAlternate Dokl Biochem Biophys
PublicationYear 2024
Publisher Pleiades Publishing
Springer Nature B.V
Publisher_xml – name: Pleiades Publishing
– name: Springer Nature B.V
References Liu, Wang, Xie (CR5) 2023; 112
Lomakin (CR9) 2022; 13
Bjornevik (CR2) 2022; 375
CR4
Kang, Kieff (CR6) 2015; 47
Diaz, Zarco, Rivera (CR11) 2019; 30
Correale, Ysrraelit, Fiol (CR10) 2012; 12
Lomakin (CR8) 2022; 14
Lomakin (CR3) 2017; 8
Kurtzke (CR12) 1983; 33
Baecher-Allan, Kaskow, Weiner (CR1) 2018; 97
Lanz (CR7) 2022; 603
M. Liu (7475_CR5) 2023; 112
M.-S. Kang (7475_CR6) 2015; 47
Y.A. Lomakin (7475_CR9) 2022; 13
Y.A. Lomakin (7475_CR8) 2022; 14
7475_CR4
C. Diaz (7475_CR11) 2019; 30
C. Baecher-Allan (7475_CR1) 2018; 97
T.V. Lanz (7475_CR7) 2022; 603
J. Correale (7475_CR10) 2012; 12
J.F. Kurtzke (7475_CR12) 1983; 33
Y. Lomakin (7475_CR3) 2017; 8
K. Bjornevik (7475_CR2) 2022; 375
References_xml – volume: 603
  start-page: 321
  year: 2022
  end-page: 327
  ident: CR7
  article-title: Clonally expanded b cells in multiple sclerosis bind EBV EBNA1 and GlialCAM
  publication-title: Nature
  doi: 10.1038/s41586-022-04432-7
– volume: 33
  start-page: 1444
  year: 1983
  end-page: 1452
  ident: CR12
  article-title: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)
  publication-title: Neurology
  doi: 10.1212/WNL.33.11.1444
– volume: 8
  start-page: 777
  year: 2017
  ident: CR3
  article-title: Exposure to the Epstein–Barr viral antigen latent membrane protein 1 induces myelin-reactive antibodies in vivo
  publication-title: Front. Immunol
  doi: 10.3389/fimmu.2017.00777
– volume: 375
  start-page: 296
  year: 2022
  end-page: 301
  ident: CR2
  article-title: Longitudinal analysis reveals high prevalence of Epstein–Barr virus associated with multiple sclerosis
  publication-title: Science
  doi: 10.1126/science.abj8222
– volume: 47
  start-page: e131
  year: 2015
  ident: CR6
  article-title: Epstein–Barr virus latent genes
  publication-title: Exp. Mol. Med
  doi: 10.1038/emm.2014.84
– volume: 13
  start-page: 803229
  year: 2022
  ident: CR9
  article-title: Deconvolution of B cell receptor repertoire in multiple sclerosis patients revealed a delay in tBreg maturation
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2022.803229
– volume: 14
  start-page: 84
  year: 2022
  end-page: 93
  ident: CR8
  article-title: Multiple sclerosis is associated with immunoglobulin germline gene variation of transitional B cells
  publication-title: Acta Nat
  doi: 10.32607/actanaturae.11794
– volume: 112
  start-page: 105443
  year: 2023
  ident: CR5
  article-title: T cell-mediated immunity during Epstein–Barr virus infections in children
  publication-title: Infect. Genet. Evol
  doi: 10.1016/j.meegid.2023.105443
– volume: 12
  start-page: 601
  year: 2012
  end-page: 609
  ident: CR10
  article-title: Benign multiple sclerosis: does it exist?
  publication-title: Curr. Neurol. Neurosci. Rep
  doi: 10.1007/s11910-012-0292-5
– volume: 30
  start-page: 215
  year: 2019
  end-page: 224
  ident: CR11
  article-title: Highly active multiple sclerosis: an update
  publication-title: Mult. Scler. Relat. Disord.
  doi: 10.1016/j.msard.2019.01.039
– ident: CR4
– volume: 97
  start-page: 742
  year: 2018
  end-page: 768
  ident: CR1
  article-title: Multiple sclerosis: mechanisms and immunotherapy
  publication-title: Neuron
  doi: 10.1016/j.neuron.2018.01.021
– volume: 112
  start-page: 105443
  year: 2023
  ident: 7475_CR5
  publication-title: Infect. Genet. Evol
  doi: 10.1016/j.meegid.2023.105443
– volume: 375
  start-page: 296
  year: 2022
  ident: 7475_CR2
  publication-title: Science
  doi: 10.1126/science.abj8222
– volume: 603
  start-page: 321
  year: 2022
  ident: 7475_CR7
  publication-title: Nature
  doi: 10.1038/s41586-022-04432-7
– volume: 13
  start-page: 803229
  year: 2022
  ident: 7475_CR9
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2022.803229
– volume: 30
  start-page: 215
  year: 2019
  ident: 7475_CR11
  publication-title: Mult. Scler. Relat. Disord.
  doi: 10.1016/j.msard.2019.01.039
– volume: 97
  start-page: 742
  year: 2018
  ident: 7475_CR1
  publication-title: Neuron
  doi: 10.1016/j.neuron.2018.01.021
– volume: 47
  start-page: e131
  year: 2015
  ident: 7475_CR6
  publication-title: Exp. Mol. Med
  doi: 10.1038/emm.2014.84
– ident: 7475_CR4
  doi: 10.1136/jnnp-2023-331868
– volume: 12
  start-page: 601
  year: 2012
  ident: 7475_CR10
  publication-title: Curr. Neurol. Neurosci. Rep
  doi: 10.1007/s11910-012-0292-5
– volume: 33
  start-page: 1444
  year: 1983
  ident: 7475_CR12
  publication-title: Neurology
  doi: 10.1212/WNL.33.11.1444
– volume: 8
  start-page: 777
  year: 2017
  ident: 7475_CR3
  publication-title: Front. Immunol
  doi: 10.3389/fimmu.2017.00777
– volume: 14
  start-page: 84
  year: 2022
  ident: 7475_CR8
  publication-title: Acta Nat
  doi: 10.32607/actanaturae.11794
SSID ssj0020235
Score 2.2938402
Snippet Multiple sclerosis (MS) is an autoimmune neurodegenerative disease leading to inevitable disability and primarily affecting the young and middle-aged...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 48
SubjectTerms Amyotrophic lateral sclerosis
Antibodies
Antibodies, Viral
Antigens
Antiviral Agents
Biochemistry
Biological and Medical Physics
Biomedical and Life Sciences
Biophysics
Disease
EBNA-1 protein
Epstein-Barr virus
Epstein-Barr Virus Infections - epidemiology
Epstein-Barr Virus Nuclear Antigens
Herpesvirus 4, Human
Humans
Immunoglobulin G
Life Sciences
Middle Aged
Multiple Sclerosis
Neurodegenerative Diseases
Peptides
Population studies
Proteins
Viral infections
SummonAdditionalLinks – databaseName: Biological Science Database
  dbid: M7P
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5BAYkLj5ZHoCAjIQ4gq0mcOskJLWwrDrBaqYB6ixInViNRu2yySP0H_GxmHCfVsqIXbllnkqw1z88zmgF4LRNdhlWquFZRjQAlbTh6xZLnCR3FZ6pq8soNm0gXi-z0NF_6A7fOl1WONtEZ6toqOiM_EBj7ousPD8P3Fz85TY2i7KofoXETblGXBOFK95YT4KJeLgS4ZJhyiVGkz2pGIjk4oUVai5OU3KbY9EtbweZ2zeRfiVPnj47v_-9OHsA9H4my2SA6D-FGY3Zhb2YQhZ9fsjfM1Ya6Q_dduDOMrLzcg98oV-wzVRoxq9nM9C3_3q7oPXiJwsjdQHvdKrdQWSpSZL1lRx8WMx6x1jCMOBlaqPU5veDLCVsOnV07NrdIamzP5m4wL7MjLWobYgUip9_zIaX0CL4dH339-In7aQ5coQPseYmRhE5liQguVyrSutQqdwN48wTNTC2zSoZNLmoEgAgCdS3q6FDLPG7QalSREo9hx1jTPAWGHCt1JmSmZZhEdVlFFaIonelE1UlWhQGEIy8L5Vud08SNH4WDPCIpttgfwNvpkYuhz8d1xPsjZwuv8l1xxdYAXk23UVkpA1Oaxq67IkY0KjFESmUATwZ5mr4mME7AaCkNINuQtImAGoFv3jHtmWsIHtF89jjGD78bhfLqf_1zF8-u38VzuIsK5KuU9mGnX62bF3Bb_erbbvXSKdofzDIqig
  priority: 102
  providerName: ProQuest
Title The Level of Anti-Viral Antigen-Specific Antibodies to EBNA-1 in the Serum of MS Patients Does not Depend on the Severity of the Disease
URI https://link.springer.com/article/10.1134/S1607672924700753
https://www.ncbi.nlm.nih.gov/pubmed/38472667
https://www.proquest.com/docview/3255423050
https://www.proquest.com/docview/2956681876
https://pubmed.ncbi.nlm.nih.gov/PMC11021220
Volume 515
WOSCitedRecordID wos001180964600004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 1608-3091
  dateEnd: 20241207
  omitProxy: false
  ssIdentifier: ssj0020235
  issn: 1607-6729
  databaseCode: M7P
  dateStart: 20230101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1608-3091
  dateEnd: 20241207
  omitProxy: false
  ssIdentifier: ssj0020235
  issn: 1607-6729
  databaseCode: 7X7
  dateStart: 20230101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1608-3091
  dateEnd: 20241207
  omitProxy: false
  ssIdentifier: ssj0020235
  issn: 1607-6729
  databaseCode: BENPR
  dateStart: 20230101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Science Database
  customDbUrl:
  eissn: 1608-3091
  dateEnd: 20241207
  omitProxy: false
  ssIdentifier: ssj0020235
  issn: 1607-6729
  databaseCode: M2P
  dateStart: 20230101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/sciencejournals
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: Springer Nature
  customDbUrl:
  eissn: 1608-3091
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0020235
  issn: 1607-6729
  databaseCode: RSV
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB7RFqReeLQ8AqVaJMQBtKof2931MSWpONAoaqDKzbLXXmGJ2lXsIPUf8LOZWT9QCCDBZRXHk13HmdmZzzOZD-C1FDbxUmW4NX6GAEXlHL1iwiNBj-K1SfModWQTajbTy2U07_7HXffV7n1K0u3ULe-IOFlQKzSJsWAgFDm6cAf20NtpssbLxdWAsqiBC6EslOYk3qUyfzvFpjPaijC3CyV_yZY6J3T-4L8u_yHc72JONm6V5BHcycsDOByXiLevb9kb5qpA3eP1A7jXklPeHsJ31CD2kWqKWGXZuGwKflWsaB58iWrHHXW9LYx7I62oHJE1FZuezcbcZ0XJMLZkuBetr2mCiwWbtz1cazapULSsGjZxFLys6mXRrhAVkDgdT9rk0WP4fD799P4D73gbuEFX1_AEYwarZIJYLTLGtzaxJnJUu5HADSWTOpVeHoUZQj2EezYLM__UyijIcX9IfRM-gd2yKvNnwPBWJVaHUlvpCT9LUj9FvGS1FSYTOvVG4PU_YGy6pubErfE1duAmFPHWfR_B2-EjN21Hj78JH_VaEXfGXcchwjCMQr1TXP7VcBrNknItSZlX6zoOEHdKDIaUHMHTVomG1UKMCDAuUiPQG-o1CFDL780zZfHFtf72iYk9CHDhd72W_byuP36L5_8k_QL20Yi68qQj2G1W6_wl3DXfmqJeHcOOWio36mPYO5vO5pd4dBHMaVQ0ojH-AMDJJNE
linkProvider Springer Nature
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB6VAioXHi0FQ4FFAg6gVf3q2j4gFEirVk2jSClVb8Zee4Ul6g2xA8o_4NfwG5lZ26lCRG89cEvWk3XsfPP4PJMZgFfCV4mdBpIr6WRIUIKco1dMeOTTo_hQpnmUmmETwXAYnp9HozX43f0XhsoqO5toDHWmJT0j3_Uw9kXXb-_ZHybfOU2NouxqN0KjgcVxPv-JlK16f9TH3_e16x7sn3465O1UAS7RENc8QY-mApEgk4ikdJRKlIzMINjIR7hnIkyFnUdehkQEyYjKvMzZUyJyc0Rv6kgP970BNzGMcENTKjhaEDzqHUMET9gBFxi1tllUx_N3x7RIa64fkJv2lv3gSnC7WqP5V6LW-L-De__bnbsPd9tIm_Ua1XgAa3m5CVu9Mqn1xZy9Yab21SQVNuF2M5JzvgW_UG_YgCqpmFasV9YFPyumtA--RGXj40luyhjNQqqpCJPVmu1_HPa4w4qSYUTN0ALPLmiDkzEbNZ1rK9bXKFrqmvXN4GGmO1m0JsiFSJze95uU2UP4fC13ZxvWS13mj4EhQhIVeiJUwvadLEmdFFmiCpUvMz9MbQvsDjuxbFu500SRb7GhdJ4fr8DNgreLj0yaPiZXCe90SIpbk1bFlzCy4OXiMBojyjAlZa5nVewi2xYYAgbCgkcNfhdn8zAOwmgwsCBcQvZCgBqdLx8pi6-m4blD8-ddF0_8rlOCy-_1z6t4cvVVvICNw9OTQTw4Gh4_hTuovG1F1g6s19NZ_gxuyR91UU2fGyVn8OW6deMPK8qFxQ
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEB5BeYhLgZZH2gKLhDhQrerHdm0fA2kEokSRAlVvlnftFZbouoodpP4DfnZn1g8UAkiIm2NPdm1nZme-ncl8AK-kMJmnIs2N9nMEKFHB0StmPBG0FR9rVSTKkU1Es1l8fp7MO57Tuq9271OS7X8aqEuTbY4uc9NxkIijBbVFkxgXBiIipxfehFuCOIMIri_OBsRFzVwIcaE0J_EurfnbIdYd00a0uVk0-Uvm1Dmk6f3_fpQHsN3FomzcKs9DuFHYHdgdW8ThF1fsNXPVoW7bfQfutKSVV7vwAzWLnVKtEasMG9um5GflksbBQ1RH7ijtTandCVVRmSJrKnbydjbmPistw5iT4Rq1uqABPi3YvO3tWrNJhaK2atjEUfOyqpdFe0O0QOL0edImlR7Bl-nJ53fvecfnwDW6wIZnGEuYSGaI4RKtfWMyoxNHwZsIXGhyGSvpFUmYIwREGGjyMPePjUyCAtcN5evwMWzZyhZPgeGrykwcythIT_h5pnyFOMrERuhcxMobgdf_mKnump0T58a31IGeUKQb730Eb4avXLadPv4mfNBrSNoZfZ2GCM8wOvWOcfqXw2U0V8rBZLaoVnUaIB6VGCRFcgRPWoUaZgsxUsB4KRpBvKZqgwC1Al-_YsuvriW4TwztQYATH_Ya9_O-_vgUe_8k_QLuzifT9PTD7OM-3EPb6iqYDmCrWa6KZ3Bbf2_Kevnc2eA1rE0rSw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Level+of+Anti-Viral+Antigen-Specific+Antibodies+to+EBNA-1+in+the+Serum+of+MS+Patients+Does+not+Depend+on+the+Severity+of+the+Disease&rft.jtitle=Doklady.+Biochemistry+and+biophysics&rft.au=Ovchinnikova%2C+L.+A.&rft.au=Dzhelad%2C+S.+S.&rft.au=Simaniv%2C+T.+O.&rft.au=Zakharova%2C+M.+N.&rft.date=2024-04-01&rft.pub=Pleiades+Publishing&rft.issn=1607-6729&rft.eissn=1608-3091&rft.volume=515&rft.issue=1&rft.spage=48&rft.epage=51&rft_id=info:doi/10.1134%2FS1607672924700753&rft_id=info%3Apmid%2F38472667&rft.externalDocID=PMC11021220
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1607-6729&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1607-6729&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1607-6729&client=summon